Amna Fatima Khan, MD
Pediatrics · Palo Alto
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Khan’s office at (650) 497-8000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A113647 · Current
Licensed to practise in California · since 2010 · expires 2028-01-31 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Pediatrics - Pediatrics
Medicaid work
$564,112 in 2024
Medicaid paid $564,112 for 7,185 billed services this clinician did in 2024, up to 140 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 1,071 | $558,052 |
| Developmental screening | 105 | $1,599 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 417 | $1,264 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 263 | $1,254 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 246 | $855 |
| Short return visit (20+ min) | 777 | $618 |
| Application of topical fluoride | 154 | $351 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, inactivated poliovirus vaccine, Haemophilus influenzae type b PRP-OMP conjugate vaccine, and hepatitis B vaccine (DTaP-IPV-Hib-HepB), for intramuscular use | 75 | $43 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 96 | $30 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) | 25 | $30 |
| Pneumococcal conjugate vaccine, 20 valent (PCV20), for intramuscular use | 170 | $16 |
| Medication list documented in medical record (COA) | 1,440 | $0 |
| 2024 | 7,185 | 22 | 140 | $564,112 |
| 2023 | 4,255 | 17 | 124 | $554,984 |
| 2022 | 3,788 | 18 | 131 | $428,318 |
| 2021 | 5,275 | 22 | 158 | $640,622 |
| 2020 | 3,347 | 18 | 137 | $393,012 |
| 2019 | 3,770 | 17 | 152 | $468,924 |
| 2018 | 2,281 | 18 | 128 | $336,132 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 1,089 | $546,159 |
| Short return visit (20+ min) | 900 | $3,233 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 418 | $2,308 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 211 | $977 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 140 | $774 |
| Application of topical fluoride | 253 | $680 |
| Developmental screening | 54 | $604 |
| Screening test, pure tone, air only | 72 | $84 |
| Bilateral quantitative screening test of visual acuity | 125 | $76 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 111 | $33 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 133 | $33 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 70 | $16 |
2022
| Clinic visit/encounter, all-inclusive | 862 | $420,186 |
| Short return visit (20+ min) | 905 | $2,975 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 369 | $1,688 |
| Developmental screening | 86 | $1,143 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 178 | $1,017 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 119 | $927 |
| Application of topical fluoride | 29 | $110 |
| Screening test, pure tone, air only | 74 | $109 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) | 57 | $49 |
| Short return visit | 37 | $48 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 120 | $26 |
| Measurement of lead | 14 | $21 |
2021
| Clinic visit/encounter, all-inclusive | 1,322 | $632,675 |
| Developmental screening | 109 | $1,811 |
| Short return visit | 772 | $1,356 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 188 | $948 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 314 | $947 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 404 | $916 |
| Short return visit (20+ min) | 402 | $847 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; second dose | 12 | $480 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 61 | $355 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 290 | $62 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 286 | $62 |
| Screening test, pure tone, air only | 32 | $60 |
2020
| Clinic visit/encounter, all-inclusive | 1,145 | $387,146 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 278 | $1,401 |
| Developmental screening | 93 | $1,330 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 323 | $1,211 |
| Short return visit (20+ min) | 463 | $820 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 92 | $521 |
| Application of topical fluoride | 90 | $194 |
| Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | 26 | $187 |
| Short return visit | 30 | $126 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 185 | $16 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 21 | $16 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 286 | $16 |
2019
| Clinic visit/encounter, all-inclusive | 1,394 | $462,084 |
| Short return visit (20+ min) | 727 | $3,279 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 317 | $1,534 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 167 | $937 |
| Return visit (30+ min) | 128 | $353 |
| Service | 103 | $272 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 91 | $189 |
| Screening test, pure tone, air only | 102 | $156 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 19 | $118 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 22 | $0 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 105 | $0 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 12 | $0 |
2018
| Clinic visit/encounter, all-inclusive | 1,010 | $331,984 |
| Short return visit (20+ min) | 361 | $1,668 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 136 | $1,131 |
| Return visit (30+ min) | 57 | $438 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 88 | $262 |
| Service | 64 | $253 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 32 | $237 |
| Screening test, pure tone, air only | 49 | $119 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) | 30 | $25 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 82 | $15 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 64 | $0 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 16 | $0 |
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 11 Part D prescriptions in 2017. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Professional record
- NPI
- 1447486048
- Licence
- CA A113647California A113647: Current · expires 2028-01-31
More record details
- Sole proprietor
- No
- Taxonomy
- Pediatrics (208000000X)
- Mailing address
- 1243 Laurel St Apt D, Menlo Park, CA, 94025
- NPI first listed
- 2009-06-09
- NPI last updated
- 2013-04-08
This is when the NPI record was last certified, not a medical board exam.